Microbicide Trials Network: Clinical Trials

16 trials sponsored by Microbicide Trials Network, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed. 4 Phase 2, 3 Phase 1, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 13Completed 3
Not applicable1Completed 1

Follow Microbicide Trials Network: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Couple User Preferences in Dual Purpose Prevention Products
HIV Prevention, Contraception Behavior
CompletedMicrobicide Trials Network4002020-01-212022-10-13
Rectal Microbicide Acceptability, Tolerability and Adherence
Placebo rectal insert, Placebo rectal suppository, Placebo rectal douche - HIV Prevention
Not applicableCompletedMicrobicide Trials Network2172019-04-262023-01-20
Microbicide/PrEP Acceptability Among Mothers and Male Partners in Africa
Focus Group Discussion (FGD), In-depth Interview (IDI) - HIV Prevention
CompletedMicrobicide Trials Network2322018-05-312022-10-14
Assessment of ASPIRE and HOPE Adherence
In-depth Interview (IDIs) or Focus Group Discussion (FGD) - HIV Prevention
CompletedMicrobicide Trials Network3022016-06-132022-10-13
Study of Dapivirine Vaginal Ring (VR) in Adolescents
placebo ring, dapivirine ring - Human Immunodeficiency Virus
Phase 2CompletedInternational Partnership for Microbicides, Inc.962014-06-272022-10-24
An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial (MTN-003)
HIV Prevention
CompletedMicrobicide Trials Network2192012-12-012021-06-23
Safety and Adherence of a Non-medicated Intravaginal Ring (IVR)
Non-medicated Intravaginal Ring - Healthy
Phase 2CompletedPopulation Council1952011-05-012017-08-15
HIV-1 Resistance at Screening for HIV Prevention Studies
HIV
CompletedMicrobicide Trials Network10742010-08-012021-06-21
Bone Mineral Density Substudy - An Ancillary Study to MTN-003
Emtricitabine/tenofovir disoproxil fumarate, Emtricitabine/tenofovir disoproxil fumarate placebo, Tenofovir disoproxil fumarate - HIV Infections
CompletedNational Institute of Allergy and Infectious Diseases (NIAID)5182009-11-012023-02-08
EMBRACE (Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure)
Pregnancy Related
CompletedMicrobicide Trials Network8732009-10-012021-06-21
Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
Tenofovir, HEC Placebo, Open label tenofovir tablet - HIV Prevention, HIV Infections
Phase 1CompletedCONRAD182009-09-012015-08-28
Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women
Emtricitabine/tenofovir disoproxil fumarate, Emtricitabine/tenofovir disoproxil fumarate placebo, Tenofovir disoproxil fumarate - HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)50292009-08-012021-10-29
Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
HIV Infections
CompletedMicrobicide Trials Network4792008-08-252021-06-21
Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women
Tenofovir disoproxil fumarate, Tenofovir gel - HIV Infections
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1682008-06-012021-10-19
Safety and Acceptability of SPL7013 Gel (VivaGelâ„¢) in Sexually Active Women
3% SPL7013 Gel (VivaGel), Placebo Gel, HEC Placebo Gel - Healthy
Phase 1CompletedStarpharma Pty Ltd612007-07-012010-06-24
Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery
Tenofovir 1% vaginal gel - HIV Infections
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)212021-10-25

Conditions studied

HIV Infections (6)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Contraception Behavior (1)  ·  HIV Seropositivity (1)

Interventions

Tenofovir (5)  ·  Emtricitabine (2)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (2)  ·  Vaginal Creams, Foams, and Jellies (2)  ·  hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine (2)  ·  astodrimer (1)

Countries

South Africa (9)  ·  Uganda (9)  ·  United States (8)  ·  Zimbabwe (8)  ·  Malawi (4)  ·  India (1)  ·  Peru (1)  ·  Puerto Rico (1)  ·  Thailand (1)  ·  Zambia (1)

Top investigators

Alexandra Minnis, PhD (1)  ·  Ariane van der Straten, PhD (1)  ·  Ariane van der Straten, PhD, MPH (1)  ·  Craig Hoesley, MD (1)  ·  Craig W. Hendrix, MD (1)  ·  Elizabeth Montgomery, PhD, MHS (1)  ·  Ian McGowan, MD, PhD (1)  ·  Jeanne Marrazzo, MD, MPH (1)  ·  Richard Beigi, MD (1)  ·  Richard Beigi, MD, MSc, FACOG (1)  ·  Sharon A. Riddler, MD (1)  ·  Sharon A. Riddler, MD, MPH (1)  ·  Sharon Hillier, PhD (1)  ·  Urvi Parikh, PhD (1)

Results publications

PMID 21505316, PMID 21930612, PMID 22900504, PMID 22943559, PMID 23065145, PMID 23383037, PMID 23585827, PMID 25350119, PMID 25350130, PMID 25651245, PMID 25931240, PMID 25969178, PMID 26123563, PMID 26155597, PMID 26544581, PMID 26850270, PMID 27146827, PMID 27247202, PMID 27465646, PMID 28178109, PMID 28658251, PMID 29268654, PMID 29957723, PMID 30346511, PMID 30383589, PMID 30666522, PMID 30683103, PMID 31929401, PMID 32524700, PMID 33278181, PMID 33325126, PMID 33389318, PMID 35674885, PMID 38066471, PMID 38494656

NIH funding

U01AI068633 (4), UM1AI068615 (4), UM1AI068633 (4), UM1AI106707 (4), 5UM1AI068633 (2), 3UM1AI068633 (1)